EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Moringa oleifera Seed Oil (MOSEIL): A Green Immunomodulator Preventing Liver Fibrosis as A Risk Factor of Hepatocellular Carcinoma

Hendra Susanto, Rizki Handayani, Khulud Rizqi Azizah, Zia Zulistya Anugrah, Ernisha Ulmafiroh, Muhammad Nova Ramadhan, Tahta Amrillah, Balqis Balqis, Husnul Khotimah, Moch Sholeh, Adeodatus Yuda Handaya

Trends in Sciences · 10.09.2026 · 24 (1) · 13960

DOI: 10.48048/tis.2027.13960 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Trends in Sciences, online erschienen am 10.09.2026. Verfasst von Hendra Susanto und 10 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study investigated the potential of Moringa oleifera seed oil (MOSEIL) as a green immunomodulatory agent for attenuating liver fibrosis through modulation of inflammatory and fibrogenic pathways. Liver fibrosis is a critical stage in the development of cirrhosis and HCC, commonly triggered by chronic inflammation and hepatotoxic injury, including CCl₄ exposure. A randomized posttest-only controlled-group design was conducted using 30 mice divided into six experimental groups. Liver fibrosis was induced by intraperitoneal CCl₄ administration. At the same time, MOSEIL was administered in 3 formulations (CF: MOSEIL ratios of 1:8, 1:16 and 1:32). Histopathological analysis, Picro Sirius Red staining, immunohistochemistry (IHC), and RT-qPCR were performed to evaluate hepatic injury, collagen deposition, inflammatory responses, and fibrogenic signaling. The results demonstrated that MOSEIL treatment, particularly in the 1:8 and 1:16 formulations, reduced hepatic necrosis, inflammatory infiltration, and collagen deposition while enhancing IL-10 expression and restoring MMP-1-mediated extracellular matrix remodeling. MOSEIL also suppressed key pro-inflammatory and pro-fibrotic mediators. Although IL-1β expression remained elevated relative to the normal control group, MOSEIL-treated groups exhibited lower IL-1β levels compared with the fibrosis control group, indicating partial attenuation of inflammatory responses. In contrast, the 1:32 formulation, which contained the highest proportion of MOSEIL, showed less consistent hepatoprotective effects than the 1:8 formulation. These findings suggest that MOSEIL exerts hepatoprotective, anti-inflammatory, and anti-fibrotic activities through immunomodulatory regulation and extracellular matrix remodeling. Therefore, MOSEIL represents a promising complementary green therapeutic candidate for attenuating liver fibrosis through immunomodulatory and anti-fibrotic mechanisms. However, further studies regarding formulation optimization, safety, and clinical translation remain necessary. HIGHLIGHTS MOSEIL reduced hepatic inflammation and necrosis in CCl₄-induced liver fibrosis mice. MOSEIL suppressed NF-κB1, TGF-β1, CTGF, and Col-1 fibrogenic signaling pathways. MOSEIL enhanced IL-10 expression and restored MMP-1-associated extracellular matrix remodeling. MOSEIL exhibited dual immunomodulatory and anti-fibrotic mechanisms in liver fibrosis. MOSEIL shows potential as a green therapeutic candidate for attenuating liver fibrosis, a major risk factor for hepatocellular carcinoma. GRAPHICAL ABSTRACT

Zitieren

APA

Susanto, H., Handayani, R., Azizah, K. R., Anugrah, Z. Z., Ulmafiroh, E., Ramadhan, M. N., Amrillah, T., Balqis, B., Khotimah, H., Sholeh, M., & Handaya, A. Y. (2026). Moringa oleifera Seed Oil (MOSEIL): A Green Immunomodulator Preventing Liver Fibrosis as A Risk Factor of Hepatocellular Carcinoma. Trends in Sciences, 24(1), 13960. https://doi.org/10.48048/tis.2027.13960

Vancouver

Susanto H, Handayani R, Azizah KR, Anugrah ZZ, Ulmafiroh E, Ramadhan MN, et al. Moringa oleifera Seed Oil (MOSEIL): A Green Immunomodulator Preventing Liver Fibrosis as A Risk Factor of Hepatocellular Carcinoma. Trends in Sciences. 2026;24(1):13960. doi:10.48048/tis.2027.13960

BibTeX
@article{Susanto2026,
  author = {Susanto, Hendra and Handayani, Rizki and Azizah, Khulud Rizqi and Anugrah, Zia Zulistya and Ulmafiroh, Ernisha and Ramadhan, Muhammad Nova and Amrillah, Tahta and Balqis, Balqis and Khotimah, Husnul and Sholeh, Moch and Handaya, Adeodatus Yuda},
  title = {Moringa oleifera Seed Oil (MOSEIL): A Green Immunomodulator Preventing Liver Fibrosis as A Risk Factor of Hepatocellular Carcinoma},
  journal = {Trends in Sciences},
  year = {2026},
  volume = {24},
  number = {1},
  pages = {13960},
  doi = {10.48048/tis.2027.13960}
}
Kostenlos starten →